William Blair downgrades Enfusion (ENFN) to a Hold
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
MarketAxess FY2024 EPS Forecast Lowered by William Blair
Equities research analysts at William Blair cut their FY2024 earnings per share estimates for shares of MarketAxess in a ...
Hosted on MSN4d
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
bovnews13h
What’s Driving Tenaya Therapeutics Inc (TNYA) Stock’s -51.39% Plunge Over the Past Month?
Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...
FY2024 EPS Estimates for Moderna Increased by William Blair
Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...
Morningstar1mon
William Blair International Growth I
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
bovnews4h
What’s Fueling Generation Bio Co (GBIO) Stock’s -61.35% Loss Below Its 200-Day SMA?
On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...
Yahoo Finance11d
William Blair Names Stewart Licudi Head of European Investment Banking
CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...
Denali Therapeutics’ (DNLI) Outperform Rating Reiterated at William Blair
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...